These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20564648)

  • 1. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study.
    Sukumvanich P; Case LD; Van Zee K; Singletary SE; Paskett ED; Petrek JA; Naftalis E; Naughton MJ
    Cancer; 2010 Jul; 116(13):3102-11. PubMed ID: 20564648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer.
    Koga C; Akiyoshi S; Ishida M; Nakamura Y; Ohno S; Tokunaga E
    Breast Cancer; 2017 Sep; 24(5):714-719. PubMed ID: 28243992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.
    Tham YL; Sexton K; Weiss H; Elledge R; Friedman LC; Kramer R
    Am J Clin Oncol; 2007 Apr; 30(2):126-32. PubMed ID: 17414460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.
    Iwamoto T; Hara F; Uemura Y; Mukai H; Watanabe T; Ohashi Y
    Breast Cancer Res Treat; 2020 Jul; 182(2):325-332. PubMed ID: 32462261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
    Swain SM; Land SR; Ritter MW; Costantino JP; Cecchini RS; Mamounas EP; Wolmark N; Ganz PA
    Breast Cancer Res Treat; 2009 Jan; 113(2):315-20. PubMed ID: 18302020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
    Yoo C; Yun MR; Ahn JH; Jung KH; Kim HJ; Kim JE; Park JY; Park KO; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):565-75. PubMed ID: 23842722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients.
    Jeon SJ; Lee JI; Jeon MJ; Lee M
    Medicine (Baltimore); 2016 Apr; 95(14):e3301. PubMed ID: 27057900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer.
    Han HS; Ro J; Lee KS; Nam BH; Seo JA; Lee DH; Lee H; Lee ES; Kang HS; Kim SW
    Breast Cancer Res Treat; 2009 May; 115(2):335-42. PubMed ID: 18506620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.
    Fornier MN; Modi S; Panageas KS; Norton L; Hudis C
    Cancer; 2005 Oct; 104(8):1575-9. PubMed ID: 16134178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.
    Jung M; Shin HJ; Rha SY; Jeung HC; Hong S; Moon YW; Kim HS; Oh KJ; Yang WI; Roh JK; Chung HC
    Ann Surg Oncol; 2010 Dec; 17(12):3259-68. PubMed ID: 20563656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].
    Li HP; Ma LW; Zhang SL; Jia TZ; Deng HJ; Zhang ZH; Liang L; Wang MP; Xiao Y; Cao BS; Chen S; Wang YF
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):848-51. PubMed ID: 17416008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer.
    Park IH; Han HS; Lee H; Lee KS; Kang HS; Lee S; Kim SW; Jung S; Ro J
    Ann Oncol; 2012 Sep; 23(9):2283-2289. PubMed ID: 22377562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study.
    Petrek JA; Naughton MJ; Case LD; Paskett ED; Naftalis EZ; Singletary SE; Sukumvanich P
    J Clin Oncol; 2006 Mar; 24(7):1045-51. PubMed ID: 16476708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea.
    Najafi S; Djavid GE; Mehrdad N; Rajaii E; Alavi N; Olfatbakhsh A; Najafi M; Bahrami A; Heidari K
    Menopause; 2011 Feb; 18(2):208-12. PubMed ID: 21037487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
    Jonat W; Kaufmann M; Sauerbrei W; Blamey R; Cuzick J; Namer M; Fogelman I; de Haes JC; de Matteis A; Stewart A; Eiermann W; Szakolczai I; Palmer M; Schumacher M; Geberth M; Lisboa B;
    J Clin Oncol; 2002 Dec; 20(24):4628-35. PubMed ID: 12488406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era.
    Minisini AM; Menis J; Valent F; Andreetta C; Alessi B; Pascoletti G; Piga A; Fasola G; Puglisi F
    Anticancer Drugs; 2009 Jul; 20(6):503-7. PubMed ID: 19339872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.
    Zhou WB; Yin H; Liu XA; Zha XM; Chen L; Dai JC; Tao AD; Chen L; Ma JJ; Ling LJ; Wang S
    BMC Cancer; 2010 Jun; 10():281. PubMed ID: 20540745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer.
    Tiong V; Rozita AM; Taib NA; Yip CH; Ng CH
    World J Surg; 2014 Sep; 38(9):2288-96. PubMed ID: 24700093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of chemotherapy-induced amenorrhea on premenopausal breast cancer: a meta-analysis of the literature.
    Zhou Q; Yin W; Du Y; Shen Z; Lu J
    Menopause; 2015 Oct; 22(10):1091-7. PubMed ID: 25783467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens.
    Pérez-Fidalgo JA; Roselló S; García-Garré E; Jordá E; Martín-Martorell P; Bermejo B; Chirivella I; Guzman C; Lluch A
    Breast Cancer Res Treat; 2010 Feb; 120(1):245-51. PubMed ID: 19575291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.